Universal Health Services, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UHS research report →
Range $156 – $290
Price Chart
About the company
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services.
- CEO
- Marc D. Miller
- IPO
- 1981
- Employees
- 102,000
- HQ
- King of Prussia, PA, US
Get TickerSpark's AI analysis on UHS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $9.04B
- P/E
- 7.26
- Fwd P/E
- 8.01
- PEG
- 0.53
- P/S
- 0.48
- P/B
- 1.35
- EV/EBITDA
- 5.34
- Div Yield
- 0.46%
- Gross Margin
- 69.75%
- Op Margin
- 10.85%
- Net Margin
- 7.96%
- ROE
- 19.54%
- ROIC
- 10.38%
Latest fiscal year · YoY change
- Revenue
- $17.36B+9.7%
- Gross Profit
- $15.71B+10.3%
- Op Income
- $1.99B
- Net Income
- $1.49B+30.4%
- EPS
- $23.42+36.5%
- OCF Growth
- -9.8%
- FCF Growth
- -24.4%
- 52W High
- $246.33
- 52W Low
- $140.08
- 50D MA
- $182.40
- 200D MA
- $176.13
- Beta
- 1.11
- RSI (14)
- 44
- Avg Volume
- 706.24K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
UHS posted solid same-facility volume growth in Q3, but adjusted EPS and EBITDA fell year over year as de novo ramp losses, mix pressure, and certain non-recurring items weighed on results.· October 28, 2026
- Adjusted EPS was $5.22, down 8% year over year; adjusted EBITDA less NCI was $625 million versus $671 million a year ago.
- Same-facility acute admissions rose 4.9% and behavioral health same-facility net revenue increased 4.0%, showing broad operating demand.
- Management said the quarter included $47 million of supplemental Medicaid benefits, $26 million of additional professional and general liability reserves, and $8.5 million of Talkspace transaction costs, partly offsetting performance.
- The company reiterated 2026 guidance but now expects results toward the lower end of the range, mainly because of slower-than-expected ramps at Palm Beach Gardens and Cedar Hill.
- UHS completed Talkspace on August 17 and is positioning it as a longer-term outpatient and referral synergy opportunity rather than an immediate earnings contributor.
For Q3 2026, UHS reported adjusted EPS of $5.22, down 8% year over year, and adjusted EBITDA less NCI of $625 million versus $671 million in Q3 2025. Operating cash flow was $637 million, compared with $381 million a year ago. Same-facility acute admissions increased 4.9%, acute ED visits rose 4.6%, and same-facility surgeries fell 0.7%; same-facility acute net revenue increased 4.7% and behavioral same-facility net revenue increased 4.0%. The quarter included a $37 million net out-of-period DPP headwind, $47 million of supplemental Medicaid benefits, $26 million of additional liability reserves, and $8.5 million of Talkspace transaction costs. Capital expenditures were $214 million in the quarter, with full-year 2026 CapEx expected to be slightly below $1 billion. The company ended with $169 million of cash, $5.7 billion of total debt, and leverage of 2.17x. Management reiterated full-year 2026 guidance from July, but said results are currently expected toward the lower end of those ranges.
Marc Miller emphasized that underlying performance improved sequentially, with acute care demand, behavioral health volumes, and labor trends all moving in a constructive direction. He framed the strategy around three priorities: expanding acute care and outpatient capacity, integrating Talkspace, and working toward Laurel Ridge recertification in 2027. His tone was optimistic but measured, repeatedly stressing that the benefits from new capacity and the Talkspace deal will build over time rather than show up immediately.
Steve Filton focused on the gap between reported results and underlying performance, citing $47 million of supplemental Medicaid benefits, $26 million of added professional and general liability reserves, and $8.5 million of Talkspace costs as key quarter items. He said acute care same-facility revenue per adjusted admission was down 1.7% reported, but would have been up about 3% after adjusting for exchange, DPP, and med-surg mix effects. He also noted $637 million of operating cash flow, $214 million of CapEx, $242 million of share repurchases in the quarter, $690 million of year-to-date repurchases, and leverage of 2.17x, while reiterating the 2x-3x target range.
Analysts pressed management on 2027 headwinds, especially Medicaid supplemental reductions, exchange pressure, and Medicaid work requirements; Filton estimated a $175 million-$200 million Medicaid supplemental headwind in 2027 and a $15 million exchange headwind from annualizing the second-half 2026 run rate, with further exchange downside possible. Questions also focused on why surgical volumes were soft and whether the acute hospitals were ramping below plan; management said the main issue is an industry-wide shift of procedures to outpatient/ASC settings, plus slower maturation at Cedar Hill and Palm Beach Gardens. On Talkspace, management said the deal is about creating a broader outpatient continuum, with most synergies expected to be revenue synergies that begin to matter in the back half of next year and build over 12-24 months.
The call highlighted broad-based same-facility volume strength in acute care and improving behavioral demand, with labor trends also moderating. Management sounded confident that new capacity, Talkspace integration, and Laurel Ridge recertification can improve earnings over time, while share repurchases, operating cash flow, and a still-manageable leverage ratio support capital allocation flexibility.
Reported earnings and EBITDA declined year over year, and management said results were below internal expectations after stripping out special items. The two key acute de novos, Palm Beach Gardens and Cedar Hill, are ramping more slowly than expected and are a meaningful drag on margins, while Laurel Ridge and future Medicaid/exchange-related policy changes create additional uncertainty. Management also acknowledged that surgical mix is softer because more procedures are shifting to outpatient settings, which limits pricing leverage in acute care.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.4%
- Shares Outstanding
- 50.40M
- Float Shares
- 47.58M
of shares held by institutions
618 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for UHS, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Alan ArmstrongSenate | Buy | Mar 27, 26 | Filing → |
| Julia LetlowHouse · LA05 | Buy | Oct 23, 25 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Mar 14, 23 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Mar 24, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 11, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Dec 6, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | May 10, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 21, 22 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Mar 18, 20 | Filing → |
| Elizabeth Pannill FletcherHouse · TX07 | Sell | Feb 26, 19 | Filing → |
| David McKinleyHouse · WV01 | Sell | Dec 17, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 6.49M | ▼ 172.34K |
| First Eagle Investment Management, LLC | 4.57M | ▲ 11.27K |
| Blackrock, Inc. | 3.90M | ▼ 159.27K |
| Vanguard Capital Management LLC | 3.30M | ▼ 96.05K |
| Dimensional Fund Advisors LP | 2.68M | ▲ 469.32K |
| Pzena Investment Management LLC | 2.61M | ▲ 637.89K |
| Vanguard Portfolio Management LLC | 2.26M | ▼ 187.20K |
| Fmr LLC | 2.14M | ▲ 721.39K |
| State Street Corp | 2.08M | ▼ 24.70K |
| Geode Capital Management, LLC | 1.99M | ▲ 19.43K |
| Invesco Ltd. | 1.71M | ▼ 241.83K |
| Arrowstreet Capital, Limited Partnership | 1.15M | ▼ 263.54K |
Held by 847 ETFs
Biggest fund positions in UHS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 18, 26 | MILLER ALAN B | other | 27,346 |
| Nov 18, 26 | MILLER ALAN B | other | 23,396 |
| Nov 18, 26 | MILLER ALAN B | other | 27,346 |
| Nov 11, 26 | Miller Marc D | other | 75,000 |
| Nov 11, 26 | Miller Marc D | other | 63,377 |
| Nov 11, 26 | Miller Marc D | other | 75,000 |
| May 27, 26 | MILLER ALAN B | other | 14,163 |
| May 27, 26 | MILLER ALAN B | other | 14,163 |
| May 27, 26 | MILLER ALAN B | other | 14,163 |
| May 27, 26 | MILLER ALAN B | other | 9,418 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our UHS coverage
Recent articles, reports, and earnings notes.
No research on UHS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UHS report →Universal Health Services (NYSE:UHS) Share Price Breaks Below Two Hundred Day Moving Average – Should You Sell?
defenseworld.net · Nov 20
Universal Health Services, Inc. Announces Dividend
globenewswire.com · Nov 18
Universal Health Services Bets on Hospital Recovery as Medicaid Payments Fall in 2027
marketbeat.com · Nov 15
Universal Health Services: The Blue Wave Makes These Shares Very Appealing (Strong Buy)
seekingalpha.com · Nov 12
Universal Health Services: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 11
Universal Health Services, Inc. (UHS) Presents at 2026 UBS Global Healthcare Conference Transcript
seekingalpha.com · Nov 10
Do Options Traders Know Something About UHS Stock We Don't?
zacks.com · Nov 9
Hospital Stocks Soared as Democrats Took Congress
247wallst.com · Nov 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.